🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Just a group of your favorite thoracic oncologists gathering in beautiful Lake Tahoe to discuss the latest in lung cancer care & research 🫁🤠 #LCAM #MATOS24 Christine Lovly, MD, PhD, FASCO Dr. Luis E. Raez Marina Garassino Edgardo S. Santos, M.D., FACP, FASCO

Both Misty Dawn Shields and Dr Christine Hann reviewed the on-going studies of #ES-SCLC. Interesting that there are several instances where biomarker selection will be incorporated in patient selection. Studies are listed in the images. #Matos24 IASLC

Looking ahead for #SCLC with Dr. Misty Dawn Shields at #MaTOS24. Where will ADCs and BiTEs make the biggest impact? What are the optimal targets and payloads? How will maintenance lurbinectedin change outcomes? What role will radiation play?

#MATOS24 Stephen V Liu, MD Georgetown Lombardi presents a case of HER2+ mutation PDL1+ lung cancer w multifocal progression post adjuvant chemo. Highlighting: -1st line activity of T-DXd (enherthu)- awaiting full study -poor response to IO -HER2 mutations & HER2 amplifications may

Lorlatinib is the first line ALK inhibitor with this benefit ALK+ International ALK Positive #lungcancer #LCSM

⁦Matthew Gubens⁩ Excellent Presentation on KRAS Inhibitor Resistance #MaTOS24 ⁦Dr. Luis E. Raez⁩ ⁦Christine Lovly, MD, PhD, FASCO⁩ ⁦Marina Garassino⁩ ⁦Edgardo S. Santos, M.D., FACP, FASCO⁩ ⁦Triparna Sen (Sen-Lab)⁩

instagram.com/reel/DC2xBJuhZ…

instagram.com/p/DBw3GEORoZE/…

The New Orleans Summer Cancer Meeting. Do not miss the big 20th year celebration of this extraordinary CME/CE event. instagram.com/p/C9pr0k9O_8d/…

Final Countdown!⏳ December 6-7, 2024 Highlights from Leading International Congresses This is your chance to gain exclusive insights into the latest breakthroughs in cancer care from the world’s top oncology experts Register now! - rb.gy/ks05u2 Edgardo S. Santos, M.D., FACP, FASCO Dr. Luis E. Raez

Finally, our lung cancer patients and pancreas cancer with NRG1 fusion protein (genomic alteration) have a new treatment. Zenocutuzumab. Remember to test all your patients with NSCLC using next generation sequencing (NGS), which includes DNA and RNA analyses. IASLC The Oncology Institute

Dr. Alexander Olawaiye from Univ of Pittsburgh kicking off the 2024 Update in Cancer Therapy here at the Hilton Aventura. Discussing the impact of BRCA as a target. The Oncology Institute FLASCO ASCO Dr. Luis E. Raez The Medical Educator Consortium Schmidt College of Medicine at Florida Atlantic Edgardo S. Santos, M.D., FACP, FASCO

Professor Pedro Barata giving the Updates in 2024 for kidney and bladder cancer in the Updates in Cancer Therapies (UCT). The Oncology Institute FLASCO The Medical Educator Consortium ASCO ESMO - Eur. Oncology Dr. Luis E. Raez Pedro C Barata, MD MSc FACP Schmidt College of Medicine at Florida Atlantic Edgardo S. Santos, M.D., FACP, FASCO Baptist Health

Begining UCT#2024 in Miami with GU and GYO sessions with Pedro C Barata, MD MSc FACP 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 dr Olawaiye UPMC #cancer #CancerAwareness The Medical Educator Consortium Edgardo S. Santos, M.D., FACP, FASCO Edgardo S. Santos, M.D., FACP, FASCO

Dr. George Simon giving the updates for immunotherapy and its resistant mechanisms after 1L in advanced NSCLC at the 2024 UCT. PD-L1 0% is still an unmet need. IASLC The Oncology Institute The Medical Educator Consortium Schmidt College of Medicine at Florida Atlantic Dr. Luis E. Raez FLASCO Baptist Health #UCT2024

Dr. Bruna Pellini talking about targeted therapies in NSCLC after ASCO and ESMO 2024. A lot of combinations available for EGFR mutant tumors, and novel indications for HER2 alterations and ROS1 here in 2024 UCT. Bruna Pellini, MD The Oncology Institute FLASCO Baptist Health Dr. Luis E. Raez

Dr. Triparna Sen lecturing on the latest approvals and where the field for SCLC is moving now here at the 2024 UCT Symposium. Triparna Sen (Sen-Lab) Dr. Luis E. Raez The Medical Educator Consortium FLASCO Schmidt College of Medicine at Florida Atlantic Edgardo S. Santos, M.D., FACP, FASCO The Oncology Institute #UCT2024

Dr. Gregory Vidal, a breast cancer expert, lecturing on the latest data in IO for patients with metastatic breast cancer. Session led by Dr. Lauren Carcas from Baptist Health South Florida at the #UCT2024. Lauren Carcas, MD Baptist Health The Medical Educator Consortium Schmidt College of Medicine at Florida Atlantic Edgardo S. Santos, M.D., FACP, FASCO

Dr. Fernando Dezarraga, GI oncologist from Baptist Health lecturing on the hottest topic in oncology: MRD in the adjuvant CRC at the 2024 Updates in Cancer Therapy. #UCT2024 The Medical Educator Consortium Baptist Health The Oncology Institute FLASCO Edgardo S. Santos, M.D., FACP, FASCO Dr. Luis E. Raez Schmidt College of Medicine at Florida Atlantic

Excited to announce the European Commission approved our chemotherapy-free combination therapy for the first-line treatment of EGFRm #NSCLC. Proud to be part of a team at #JNJOncology that continues to drive innovation for patients. bit.ly/4gz7u8k